Cargando…
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
To evaluate the efficacy and safety of ursodeoxycholic acid (UDCA) with oral solubilized formula in amyotrophic lateral sclerosis (ALS) patients, patients with probable or definite ALS were randomized to receive oral solubilized UDCA (3.5 g/140 mL/day) or placebo for 3 months after a run-in period o...
Autores principales: | Min, Ju-Hong, Hong, Yoon-Ho, Sung, Jung-Joon, Kim, Sung-Min, Lee, Jung Bok, Lee, Kwang-Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271295/ https://www.ncbi.nlm.nih.gov/pubmed/22323869 http://dx.doi.org/10.3346/jkms.2012.27.2.200 |
Ejemplares similares
-
Diffusion Tensor Tractography Analysis of the Corpus Callosum Fibers in Amyotrophic Lateral Sclerosis
por: Kim, Jee-Eun, et al.
Publicado: (2014) -
Amyotrophic Lateral Sclerosis Is Associated with Hypolipidemia at the Presymptomatic Stage in Mice
por: Kim, Sung-Min, et al.
Publicado: (2011) -
25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
por: Kim, Sung-Min, et al.
Publicado: (2017) -
Altered nucleocytoplasmic proteome and transcriptome distributions in an in vitro model of amyotrophic lateral sclerosis
por: Kim, Jee-Eun, et al.
Publicado: (2017) -
Motor Unit Number Estimation in Evaluating Disease Progression in Patients with Amyotrophic Lateral Sclerosis
por: Ahn, Suk-Won, et al.
Publicado: (2010)